Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease

Clinical Cardiology

Volumn 30, Issue 2, 2007, Pages 86-91

  Wang, Ying ^a   Li, Li ^a   Tan, Hong Wei ^a   Yu, Guang Sheng ^b   Ma, Zhi Yong ^a   Zhao, Yu Xia ^b   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Coronary disease; HsC reactive protein; Inflammation; Soluble CD40 ligand

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; HSC REACTIVE PROTEIN; SOLUBLE CD40 LIGAND; UNCLASSIFIED DRUG;

ADULT; AORTA ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; FEMALE; FEMORAL VEIN; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; RELIABILITY; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD40 LIGAND; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED;

EID: 33847053908     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.26     Document Type: Article

References (17)

1. Scarabin PY, Arveiler D. Amouyel P: Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland: The PRIME study. Atherosclerosis 2003;166:103-109
2. Ridker PM, Rifai N, Rose L: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565
3. Lutgens E, Daemen MJ: CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 2002;12:27-32
4. Schon̈beck U, Libby P: CD40 signaling and plaque instability. Circ Res 2001;89:1092-1103
5. Aukrust P, Muller F, Ueland T: Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999;100:614-620
6. Cipollone F, Mezzetti A, Porreca E: Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: Effects of statin therapy. Circulation 2002;106:399-402
7. Schon̈beck U, Varo N, Libby P: Soluble CD40L and cardiovascular risk in women. Circulation 2001;104:2266-2268
8. Ejiri J, Inoue N, Kobayashi S: Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 2005;112:2114-2120
9. Ambrose JA, Winters SL, Arora RR: Coronary angiographic morphology in myocardial infarction: A link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985;6:1233-1238
10. Chester MR, Chen L, Tousoulis D: Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease. J Am Coll Cardiol 1995;25:837-842
11. Yasuda T, Shimizu M, Ino H: Coronary lesion morphology and prognosis in young males with myocardial infarction with or without familial hypercholesterolemia. Jpn Circ J 2001;65:247-250
12. Kinlay S, Schwartz GG, Olsson AG: Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MTRACL) Study. Circulation 2004;110:386-391
13. Heeschen C, Dimmeler S, Hamm CW: Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-1111
14. Varo N, de Lemos JA, Libby P: Soluble CD40L: Risk prediction after acute coronary syndromes. Circulation 2003;108:1049-1052
15. Ohashi Y, Kawashima S, Mori T: Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarc-tion. Int J Cardiol 2006;112:52-58
16. Andre P, Nannizzi-Alaimo L, Prasad SK: Platelet-derived CD40L: The switch-hitting player of cardiovascular disease. Circulation 2002;106:896-899
17. Inoue T, Kato T, Uchida T: Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol 2005;46:239-245